Why do some people with aspergillosis lose weight on the hips and thighs, but gain around the waist?

Many people living with aspergillosis, bronchiectasis or ABPA notice their body shape changing as they get older — especially after 60.
A very common pattern is:

  • Thinner hips and legs

  • More weight around the waist or tummy

This can feel confusing, but there are clear reasons why it happens.

1. Chronic lung conditions make it harder to keep leg and hip muscle

When you live with a long-term lung condition, you often have:

  • Breathlessness

  • Fatigue

  • Repeated chest infections

  • Less ability to walk long distances or climb stairs

Because the legs work harder than any other muscles, they are the first to lose strength and size when activity drops.
This is why many people notice:

  • Slimmer thighs

  • Smaller hips

  • Feeling weaker when getting out of a chair

This is partly due to age, but it happens faster in people with chronic lung disease.

2. Steroids can move weight from the limbs to the waist

Many aspergillosis patients have had:

  • Several courses of prednisolone over the years

  • High-dose inhaled steroids

  • Hydrocortisone replacement for adrenal problems

Even short or occasional courses can cause fat redistribution, where:

  • Fat and muscle reduce in the arms, hips and legs

  • More fat settles around the stomach area

  • The centre of the body becomes rounder even if the overall weight hasn’t changed much

This effect can continue long after stopping steroids.

3. Ageing naturally shifts fat towards the waist

After about age 60, the body changes how it stores fat:

  • Less around the hips and thighs

  • More around the waist

  • More “internal” fat around organs (visceral fat)

This happens to everyone, but can be more noticeable in people with aspergillosis because illness already reduces leg muscle.

4. You can lose muscle even if weight on the scales stays the same

Many patients say,
“I feel thinner and thicker at the same time.”

That’s because:

  • Muscle in the legs may be lost

  • Fat around the waist may increase

  • The total body weight doesn’t always change much

This is a normal pattern in long-term lung disease.

5. Illness, flare-ups, infections and poor appetite add to this

During flare-ups or infections, it’s common to:

  • Eat less

  • Feel exhausted

  • Lose muscle faster

  • Keep or gain tummy fat

The body burns muscle first when unwell, not fat — especially not tummy fat.

Is this dangerous?

Not usually on its own — but it does mean:

  • Legs may feel weaker

  • Balance and stamina can reduce

  • It may be harder to stay active

Strength and gentle exercise (within your limits) can help rebuild some leg muscle.

If weight changes are sudden or unexplained, they should always be discussed with your GP or specialist.

In summary

This body-shape change is very common in people with aspergillosis over 60.
It’s caused by a combination of:

  • Reduced activity due to breathlessness

  • Loss of leg and hip muscle

  • Steroid effects on fat distribution

  • Natural age-related changes

  • Appetite changes during illness

It doesn’t mean you’re doing anything wrong — it’s simply a pattern seen in many people with long-term lung disease.

by GAtherton

COVID Vaccines: Yes, There Is Some Risk — But COVID Infection Causes Far More Harm

People living with aspergillosis, CPA, ABPA, bronchiectasis, asthma or sarcoidosis often feel understandably anxious about vaccination.
Concerns about myocarditis, side effects, and frightening stories online are completely normal.

But when you compare the risks of the vaccine with the risks of COVID infection, a clear picture emerges:

⚠️ The vaccine carries some risk

🚨 COVID infection carries far, far more risk — and affects almost everyone

This article explains that difference clearly and honestly.

1. COVID vaccines can cause harm — but this is rare

No medical treatment is risk-free.
A very small number of people experience:

  • Fever

  • Fatigue

  • Headache

  • Swollen glands

  • Sore arm

  • Mild myocarditis (usually short-lived, rare, and mostly in young men)

Serious reactions such as hospitalisation or anaphylaxis are extremely rare — roughly 1–2 cases per million doses.

We should acknowledge this openly.

2. Almost everyone has had COVID in the last five years

Across the UK and most of the world, over 90% of adults now show antibodies from a past COVID infection, even if they didn’t realise they had it.

Many infections felt like a cold or passed unnoticed, but the body still experienced real risks:

  • heart inflammation

  • blood clots

  • lung inflammation

  • long-term fatigue

  • worsening of existing lung disease

Many people have had COVID more than once, and the risks increase with repeated infections.

So when we compare vaccine risk with infection risk, we’re not discussing a rare scenario — we are talking about something nearly everyone has already experienced, often multiple times.

3. COVID vaccines have prevented millions of hospitalisations and deaths

Global studies estimate that:

  • In the first year alone, COVID vaccines prevented around 19 million deaths worldwide.

  • WHO Europe reports more than 1.4 million lives saved in Europe alone.

  • A wider analysis suggests vaccines prevented over half of all potential hospitalisations and severe outcomes across many countries.

A simple way to think about it:

For every serious vaccine reaction, the vaccine prevents tens of thousands of hospitalisations and deaths.

This benefit is especially important for people with:

  • chronic lung disease

  • aspergillosis

  • bronchiectasis

  • asthma

  • immune suppression

  • long-term steroid use

For these groups, the protective effect of vaccination is greater than average, because COVID complications are more dangerous.

4. COVID infection causes far more harm than the vaccine

This is the crucial point.

COVID infection is 30–100 times more likely to cause myocarditis than the vaccine.

And infection-related myocarditis is:

  • more severe

  • more likely to require hospital care

  • more likely to leave long-term effects

COVID infection also increases the risk of:

  • blood clots

  • heart attacks

  • strokes

  • lung scarring

  • long COVID

  • ICU admission

  • worsening of asthma, ABPA, CPA and bronchiectasis

And the risk of death from infection is hundreds of times higher than the risk from vaccination.

5. Why scare stories feel louder than scientific facts

Scary individual stories spread quickly online.
But they are rare.

What we don’t see in the same dramatic way:

  • “Thousands of vulnerable patients avoided severe illness because they were vaccinated.”

  • “Vaccination prevented hospital admissions this week.”

  • “Most myocarditis cases after vaccination recover fully within days.”

Positive outcomes never go viral — but they happen constantly.

6. What this means for people with aspergillosis

COVID infection can:

  • trigger ABPA flares

  • worsen CPA cavities

  • increase mucus blockage

  • increase breathlessness

  • raise the risk of secondary fungal infections

  • accelerate lung damage

  • lead to hospitalisation

Vaccination significantly reduces all of these risks.

For most people with aspergillosis, vaccination is far safer than repeated COVID infections.

7. A supportive message for anyone still unsure

“It's true the vaccine carries some risk — all medicines do.
But COVID infection carries far, far more risk, and nearly everyone has had it at least once already.
Vaccination is the option that best protects your heart, your lungs, and your long-term health.”

by GAtherton

🌡️ Understanding Body Temperature in Aspergillosis: Why Your Fever May Look Different

Many people living with aspergillosis—including allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), severe asthma with fungal sensitisation (SAFS) and Aspergillus bronchitis—notice that their body temperature behaves differently from what doctors call “normal.”

This is especially common in people who are:

  • On long-term steroids

  • Tapering steroids

  • Living with adrenal insufficiency

  • Older adults

  • On biologics

  • Managing chronic lung disease

This guide explains why your temperature may run lower, why fevers can appear smaller or absent, and how to safely manage this.

🔶 1. Many aspergillosis patients have a lower baseline temperature

Although “37.0°C” is often quoted, most patients actually sit anywhere between 35.5–36.5°C.
Reasons include:

✔ Long-term steroids

Prednisolone, methylprednisolone, hydrocortisone, and even high-dose inhaled steroids can blunt the immune response and lower your resting temperature.

✔ Adrenal insufficiency

If your adrenal glands are suppressed, your body’s ability to raise temperature is reduced.
You may get no fever at all, even with infections.

✔ Chronic lung disease

Living with ABPA, CPA or bronchiectasis can change how your body regulates heat.

✔ Biologic treatments

Some biologics influence inflammatory signalling and may soften fever responses.

✔ Age

Older adults naturally have:

  • Lower metabolism

  • Lower baseline temperature

  • Reduced ability to generate fever (“immune senescence”)

Many older aspergillosis patients sit around 35.7–36.2°C when completely well.

🔶 2. Fever is a rise from your normal — not a single number

For someone with a naturally low temperature, a fever may look very different.

A useful rule:

A fever = a rise of 1°C above your personal baseline,
even if the thermometer is below 38°C.

Example

  • Your baseline = 35.8°C

  • Your fever may begin at 36.8–37.0°C

You may feel shivery, hot, exhausted or “flu-ish” long before hitting 38°C.

🔶 3. Why fevers are often “muted” in aspergillosis

✔ Steroids

Reduce the body’s ability to trigger a strong fever.

✔ Adrenal insufficiency

Greatly reduces your ability to raise temperature; infections may show as fatigue, dizziness, nausea or sudden weakness instead.

✔ Age

Older adults may have:

  • No fever

  • A tiny rise

  • Confusion or breathlessness as the only sign of infection

✔ Chronic disease

Your temperature regulation system may simply behave differently because of long-term inflammation.

🔶 4. What YOU can do to manage this safely

✔ Know your personal baseline

Measure your temperature twice daily for 5–7 days when well.
Record the average — this is your true normal.

✔ Treat a 1°C rise as your own fever

Don’t wait for the thermometer to reach 38°C.

✔ Watch symptoms more than the number

Seek medical advice if you notice:

  • Feeling feverish or shivery

  • Breathing worsening

  • New chest or flank pain

  • Sudden exhaustion

  • Increased heart rate

  • Confusion, dizziness or “not right”

  • New cough or change in sputum

These can indicate infection even without a high temperature.

✔ Keep a symptom + temperature chart

Especially if you:

  • Are on steroids

  • Have adrenal insufficiency

  • Are tapering

  • Are on biologics

  • Have recurrent infections

Even simple notes help clinicians hugely.

✔ Tell every clinician your temperature baseline

Not all doctors will know your usual pattern, so tell them:

“My normal temperature is around X°C.
I don’t get high fevers because of chronic illness/steroids/adrenal suppression.
A small rise is significant for me.”

This is important in GP appointments, A&E, respiratory clinics and hospital admissions.

🔶 5. Extra precautions if you have adrenal insufficiency

People with steroid-induced adrenal suppression must be especially careful:

  • A small temperature rise + feeling unwell may mean you need stress-dose steroids

  • Vomiting, dizziness, intense fatigue or confusion are warning signs

  • Always follow your adrenal emergency plan

  • Always carry your Steroid Emergency Card and hydrocortisone emergency injection if prescribed

🔶 6. Do doctors understand this?

Most clinicians understand the general rules:

  • Older adults often do not mount high fevers

  • Steroids blunt fever

  • Adrenal insufficiency changes the febrile response

  • Infection may present atypically

However, few clinicians know your personal baseline unless you tell them.

Sharing your own numbers helps them interpret your symptoms safely and accurately.

🟩 Summary for Aspergillosis Patients

  • Many people with aspergillosis have a naturally lower temperature.

  • Steroids, adrenal insufficiency and age can all reduce your ability to produce a fever.

  • A rise of 1°C above YOUR normal may be your fever.

  • Focus on overall symptoms, not just the thermometer.

  • Tell every clinician your baseline temperature.

  • Take extra care if you have adrenal insufficiency.

by GAtherton

Side effects from Biologic Medication

It’s completely understandable to feel unsure before starting a biologic — especially when you’ve heard different experiences from different people.
Most patients with ABPA or severe Aspergillus-related asthma do very well on biologics. Side effects can happen, but they’re usually mild and settle quickly.

🌟 Most people report very few problems

Patients often say:

  • The injections are straightforward

  • They feel the same or better within days or weeks

  • There’s little or no impact on daily life

🌟 Common, mild side effects

These are the ones we hear most often across omalizumab, benralizumab, dupilumab and tezepelumab:

📌 Injection-site reactions

  • Redness

  • Itching

  • A small tender lump

  • Bruising
    These usually disappear within 24–48 hours.

📌 Mild tiredness

Some people feel slightly “wiped out” after the first few doses.

📌 Headache

Very common with the first injection. Less so afterwards.

📌 Minor joint or muscle aches

A bit like the feeling after a flu jab.

📌 Nasal or sinus changes

Occasional mild dryness or congestion, especially with dupilumab.

🌟 Less common (still mild)

  • Mild tummy upset

  • Sore throat

  • A brief “flu-ish” feeling

  • Temporary increase in eczema (mainly with dupilumab)

  • Slight mood dip for a day or two (rare)

🌟 Rare but important

These are very uncommon, and your team will explain what to look out for:

  • Allergic reaction shortly after an injection
    (This is why your first dose is supervised.)

  • Eye inflammation — mostly linked to dupilumab, usually mild and treatable

Your team will give you clear advice on what to do if anything unusual happens.

🌟 What ABPA patients often notice

People with ABPA frequently describe:
👉 Fewer allergic symptoms
👉 Clearer breathing
👉 Much less mucus
👉 Fewer flare-ups and fewer steroids

But biologics don’t help everyone — which is why the first few months are monitored closely.

🌟 Final reassurance

For many aspergillosis patients, biologics are far easier than long-term steroids or antifungals. Most say the benefits outweigh the side effects — but every person’s experience is individual.

by GAtherton

**Adrenal Insufficiency & Steroid Tapering:

A Complete Patient Guide**

People taking long-term steroids (prednisolone, methylprednisolone, hydrocortisone, dexamethasone) can develop adrenal insufficiency because their adrenal glands “go to sleep” and stop making cortisol.
During tapering, the body must slowly “wake up” again — and this needs careful monitoring.

This guide explains the symptoms, tests, warning signs, and emergency precautions to keep you safe.

⭐ 1. Why adrenal insufficiency happens

Long-term steroid use suppresses the HPA axis (hypothalamus–pituitary–adrenal system).
When daily steroid doses are reduced, your body must produce more of its own cortisol. This takes time.

If the steroid reduction is too quick, or the body is under stress, low cortisol symptoms appear.

⭐ 2. Symptoms to watch for during steroid tapering

These are early signs that your body may not be keeping up with the reduction.

✔ Early, mild symptoms

  • Fatigue / sudden exhaustion

  • Muscle weakness

  • Dizziness when standing

  • Nausea or reduced appetite

  • Flu-like aching

  • Low mood, anxiety, irritability

  • Brain fog

  • Feeling unusually cold

  • Worsening joint or muscle pain

These often improve if the taper is slowed or paused.

⭐ 3. More serious symptoms of low cortisol

These symptoms suggest steroid levels are too low and the taper needs urgent review:

  • Vomiting

  • Persistent dizziness

  • Very low blood pressure

  • Severe fatigue (unable to function normally)

  • Salt cravings

  • Ongoing nausea preventing eating

  • Faintness or near-collapse

These require medical advice (same day).

⭐ 4. Emergency symptoms — possible adrenal crisis

Call 999 or go to A&E immediately if you develop:

  • Severe vomiting or diarrhoea

  • Collapse or inability to stand

  • Severe dehydration

  • Confusion

  • Sudden severe abdominal or back pain

  • Pale, clammy skin

  • Rapid breathing

  • Loss of consciousness

This is a medical emergency.
Patients normally receive 100 mg hydrocortisone IM/IV, but patients allergic to hydrocortisone require a pre-agreed emergency alternative — your endocrinologist must document this clearly.

⭐ 5. Symptoms that mean you may need a temporary “stress dose” of steroids

Your cortisol requirement increases during physical stress.
If you have adrenal suppression, your body cannot produce this extra cortisol.

You may need a temporary increase in dose if you have:

✔ Illness

  • Fever

  • Chest infection

  • Flu-like illness

  • COVID

  • Urinary infection

  • Gastroenteritis

  • Diarrhoea

  • Persistent nausea

✔ Physical stress

  • Injury

  • Significant fall

  • Severe pain

  • Dental surgery

  • Medical or surgical procedures

✔ Emotional stress

  • Bereavement

  • Panic attacks

  • Trauma

If vomiting prevents taking steroids → seek emergency help immediately.

⭐ 6. Tests used to monitor adrenal function during tapering

Doctors rely on a combination of symptoms and laboratory tests.

✔ Morning cortisol (8–9 am)

A key test to assess recovery.

Typical interpretation:

  • > 400–500 nmol/L → likely normal function

  • 150–350 nmol/L → recovering / borderline

  • < 100 nmol/L → adrenal insufficiency

(Exact thresholds vary.)

✔ ACTH level

Shows whether the pituitary is trying to stimulate the adrenals.

  • Low ACTH → still suppressed

  • High ACTH → trying to wake adrenals

  • Normal ACTH + low cortisol → gland slow to respond

✔ Short Synacthen Test (SST)

Gold standard.
A small ACTH injection tests whether your adrenal glands can produce cortisol.

Used when:

  • taper reaches low doses

  • symptoms appear

  • deciding if steroids can be stopped

✔ Electrolytes (U&Es)

Low cortisol may cause:

  • Low sodium

  • High potassium (less common in steroid-induced insufficiency)

✔ Blood pressure monitoring

Low cortisol → low BP, dizziness, faintness.

✔ Glucose levels

Low-normal glucose and shakiness may occur during withdrawal.

✔ Clinical symptom review

Symptoms are sometimes more sensitive than tests.

Doctors track:

  • fatigue

  • appetite

  • dizziness

  • illness triggers

  • salt cravings

  • mental state

  • recovery after small dose increases

⭐ 7. How tapering decisions are made

Tapering depends on:

  • how long steroids have been taken

  • current dose

  • symptoms

  • test results

  • presence of illness

  • rate at which symptoms develop

  • allergy restrictions (pred/hydrocortisone allergy requires specialist handling)

General principles (not schedules):

  1. Higher doses can reduce more quickly.

  2. Taper slows dramatically near physiological levels
    (~4–6 mg pred-equivalent).

  3. If symptoms appear → pause, slightly increase, or slow taper.

  4. SST is used near the end to confirm recovery.

⭐ 8. When to contact your medical team

Same day advice needed

  • worsening dizziness

  • persistent nausea

  • new vomiting

  • symptoms appear with each taper step

  • fainting

  • new severe fatigue

  • any infection (urinary, chest, flu)

Urgent / A&E

  • collapse

  • severe vomiting/diarrhoea

  • confusion

  • severe abdominal pain

  • unable to take oral steroids

  • suspected adrenal crisis

⭐ 9. What patients should do to stay safe

  • Carry a Steroid Emergency Card at all times

  • Keep emergency instructions from your endocrinologist

  • Know your Sick Day Rules

  • Ensure A&E or ambulance crews know about corticosteroid allergy

  • Keep a written record of tapering plan

  • Never stop steroids suddenly

  • Be cautious during illness

  • Know your emergency steroid plan (alternative if allergic to hydrocortisone)

⭐ Final reassurance

Adrenal insufficiency during tapering is common, manageable, and often reversible.
By monitoring symptoms, using regular blood tests, and following specialist guidance, tapering can be done safely.

You are not alone — your endocrine team will guide every step, especially if allergies (to prednisolone or hydrocortisone) make your case more complex.

With careful observation and a clear emergency plan, serious complications are rare and preventable.

by GAtherton

🌿 Your Immune System, Biologics, and Steroids: What’s Suppressed — and What Stays Strong

A clear, reassuring guide for people living with ABPA, CPA, asthma, SAFS, or bronchiectasis

Treatments for aspergillosis-related conditions often involve steroids, and more recently, biologics.
Many patients understandably wonder:

  • What do these medicines suppress?

  • Do they affect my ability to fight infection?

  • Why are biologics considered safer than long-term steroids?

  • Which parts of my immune system stay strong?

This guide explains the full picture in simple terms.

🧬 1. Understanding Your Immune System: The Three Layers

Your immune system has three major lines of defence.

⭐ A. Barriers — the first line

These stop pathogens entering in the first place:

  • Skin

  • Mucus in airways

  • Cilia sweeping mucus out

  • Tears, saliva, stomach acid

  • Healthy bacteria (microbiome)

👉 Biologics do NOT affect barriers.
👉 Steroids can weaken skin and airway lining if used long-term.

⭐ B. Innate immunity — fast responders

These act within minutes or hours.

Key cells:

  • Neutrophils → main killers of Aspergillus

  • Macrophages → engulf spores

  • Dendritic cells → show pathogens to T-cells

  • NK cells → kill virus-infected cells

Sensors:

  • Dectin-1 → recognises fungal walls

  • TLRs

  • Complement proteins

👉 Biologics do NOT weaken these.
👉 Steroids weaken several key functions, especially neutrophils and macrophages.

⭐ C. Adaptive immunity — targeted, long-term defence

Slower but specialised.

T-cells:

  • Th1 → fight bacteria/viruses

  • Th17 → major antifungal fighters

  • Th2 → allergic pathways (IgE, eosinophils)

  • Tregs → calm inflammation

B-cells & antibodies:

  • IgG / IgA / IgM → normal infection defence

  • IgE → allergy and ABPA pathway

👉 Biologics only suppress Th2/IgE pathways.
👉 Steroids suppress many T-cell and B-cell functions, not just allergy.

🎯 2. What Biologics Suppress (Targeted & Selective)

Biologics used in ABPA and difficult asthma (omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab) only turn down allergic inflammation, not infection-fighting immunity.

🔻 A. They suppress:

  • IgE

  • Eosinophils

  • IL-4 / IL-5 / IL-13

  • Type-2 allergic inflammation

  • Mucus hypersecretion (IL-13)

  • TSLP airway alarm signalling

🛡️ B. They do NOT suppress:

  • Neutrophils

  • Macrophages

  • Th1 immunity

  • Th17 antifungal pathways

  • T-cell killing function

  • Antibiotic/cell-mediated defences

  • Complement

  • Dectin-1 fungal recognition

This is why biologics do NOT increase fungal infection risk.

🔥 3. What Oral Steroids Suppress (Broad & Non-Specific)

Oral steroids like prednisolone reduce inflammation everywhere — including places you need for infection defence.

❌ A. They suppress key immune cells

  • Neutrophils → move slower, kill less effectively

  • Macrophages → reduced pathogen killing

  • T-cells → weaker antiviral/antifungal defence

  • B-cells → reduced antibody production

❌ B. They suppress important cytokines

  • IL-1, IL-2, IL-6

  • TNF-α

  • Interferons

  • IL-12, IL-23 (Th1/Th17 pathways)

These are essential for fighting viruses, bacteria, and fungi.

❌ C. They weaken antigen presentation

Dendritic cells and macrophages become less effective at “showing” pathogens to T-cells.

❌ D. They weaken barriers

  • Thinner skin

  • Thinner airway lining

  • Slower wound healing

This increases infection risk.

❌ E. They reduce eosinophils and IgE (similar to biologics)

But they do this alongside suppressing many healthy parts of your immune system.

🛡️ 4. What Remains Intact on Each Treatment

✔ On biologics (strongest preserved immunity):

  • Neutrophil antifungal killing

  • Macrophage function

  • Th1 & Th17 immunity

  • Antibodies (IgG, IgA, IgM)

  • Complement

  • Mucus & cilia defences

  • NK cell antiviral defence

  • Fever & inflammation responses

⚠️ On steroids (weaker preserved immunity):

  • Complement

  • Some antibody production

  • Basic barrier function (though thinner)

Many infection-fighting cells work less effectively.

🫁 5. Why Biologics Are Safer Long-Term for ABPA/SAFS

Because biologics:

  • target only a tiny portion of immunity

  • do not increase fungal growth

  • do not raise infection risk

  • reduce inflammation without broad suppression

  • help avoid long-term steroid complications

Steroids:

  • increase infection risk

  • can worsen fungal colonisation

  • damage lung structure over time

  • cause weight gain, bone thinning, adrenal issues

  • must be used short-term only when essential

🌈 6. Summary Table

Immune Feature Biologics Steroids
IgE suppression ✔ ✔
Eosinophil suppression ✔ ✔
Neutrophils Unaffected Suppressed
Macrophages Unaffected Suppressed
Th1/Th17 antifungal pathways Unaffected Suppressed
Viral defence Unaffected Suppressed
Barrier integrity Unaffected Weakened
Infection risk No increase Increased
Long-term safety High Low

🌟 7. One-Sentence Takeaway

Biologics turn down the allergic part of immunity (IgE, IL-4, IL-5, IL-13, eosinophils), while steroids suppress many of the infection-fighting parts as well — which is why biologics are much safer long-term.

by GAtherton

Inhaled Steroids and ABPA: Do They Help or Should They Be Avoided?

Many people living with allergic bronchopulmonary aspergillosis (ABPA) also use inhaled steroid inhalers such as Symbicort, Fostair, Seretide or Clenil. It’s common to feel confused about whether these inhalers help, whether they should be continued, or whether they could cause harm.

This guide explains what inhaled steroids do, what they don’t do, and how they fit into the treatment of ABPA, asthma, and bronchiectasis.

1. Understanding the basics

What are inhaled steroids?

Inhaled corticosteroids (ICS) are medications breathed directly into the lungs to reduce airway inflammation, especially in asthma. Combination inhalers (e.g., Symbicort, Fostair) contain a steroid + a long-acting bronchodilator.

What they don’t do

Inhaled steroids do not treat ABPA itself.
ABPA is caused by an immune over-reaction to Aspergillus in the lungs. This reaction sits too deep in the airways for inhaled steroids to reach, and the inflammation is too strong for inhaled doses to control.

This is why ABPA flares are treated with:

  • Oral steroids, or

  • Biologics, such as mepolizumab, benralizumab, dupilumab or omalizumab.

2. Why inhaled steroids are still useful for many ABPA patients

Although inhaled steroids don’t treat ABPA directly, most people with ABPA also have asthma.
In asthma:

  • the airways are twitchy

  • inflamed

  • narrow easily

  • and respond well to inhaled steroids

If your symptoms include wheeze, chest tightness, breathlessness that varies from day to day, or a good response to your reliever inhaler, there is a strong chance that asthma is part of your condition.

In those cases, inhaled steroids can be very helpful in keeping the asthma component under control.

3. When inhaled steroids may offer little benefit

Some patients with ABPA have:

  • minimal asthma

  • mainly bronchiectasis

  • or are fully controlled on a biologic

In these situations, inhaled steroids might not provide much additional benefit and occasionally can increase the risk of airway infections, especially in people with significant bronchiectasis.

This is why doctors sometimes sound vague: the answer genuinely depends on your individual mix of ABPA, asthma, and bronchiectasis.

4. How biologics change the picture

Biologics used for ABPA and asthma (e.g., benralizumab, mepolizumab, dupilumab) reduce airway inflammation far more effectively than inhaled steroids. Once a patient is stable on a biologic, many specialists will slowly reduce the inhaled steroid dose if asthma symptoms remain well-controlled.

This does not happen quickly — it is done gradually and only if your breathing tests and symptoms stay stable.

5. Why there is no simple “yes” or “no” answer

Doctors often hesitate to give a straight answer because inhaled steroids can be:

  • Essential for asthma

  • Optional for mild asthma

  • Less useful if ABPA is the main issue

  • Potentially overused in some bronchiectasis patients

  • Safely reduced in people doing well on biologics

Your treatment has to sit in the right place on that spectrum.

6. Questions that can help you get a clear answer from your own team

Many patients say they receive vague responses. These direct questions can help:

✔ “Am I using this inhaler for my asthma, or for my ABPA?”

(If it’s for ABPA, that usually signals a misunderstanding.)

✔ “Do you think my asthma is active, and is the dose of inhaled steroid still appropriate?”

This invites your clinician to be specific.

✔ “If I stay stable on my biologic, could we review the inhaled steroid dose in the future?”

This aligns with typical specialist practice.

7. The bottom line

  • Inhaled steroids do not treat ABPA itself.

  • They are helpful if you also have asthma — which many ABPA patients do.

  • They may be less useful if asthma is mild or absent, especially in pure bronchiectasis.

  • When patients stabilise on biologics, inhaled steroid doses are often reviewed and sometimes reduced.

  • The best approach is individual: the right treatment mix varies from patient to patient.

If you’re unsure what role your inhaler is playing, it’s absolutely reasonable to ask your specialist to explain exactly why you’re on it and whether the dose is still right for you.

by GAtherton

🌬️ Breathing Easier: Keeping Your Air Clean at Home, Work and When Travelling

People with lung conditions such as aspergillosis, asthma, or bronchiectasis often find their symptoms worsen in certain environments — especially where the air feels dusty, damp, or polluted.
The good news is that there are simple, practical steps you can take to control your surroundings, reduce flare-ups, and make your home a safer, healthier place to breathe.

🏠 At Home

Keep It Dry and Well-Ventilated

  • Tackle damp and leaks early. Mould thrives in moist places — even hidden behind furniture or under wallpaper.

  • Trust your nose. If something smells damp, it probably is. A musty smell means moisture is trapped somewhere — investigate and dry it before mould can grow.

  • Ventilate daily. Open windows when outdoor air is clean, or use extractor fans in kitchens and bathrooms.

  • Prevent moisture spreading. When showering, cooking, or drying laundry, close doors to other rooms so steam and humidity don’t spread through the house.

    • Run the extractor fan during and for at least 15–20 minutes afterwards, or until humidity drops.

    • Short humidity spikes are normal. It’s common for relative humidity (RH) to rise above 60% during cooking, showering, or drying clothes — what matters is that it returns below 60% quickly once fans or windows are open.

    • If condensation lingers or humidity stays high for more than 30–40 minutes, increase ventilation or use a dehumidifier.

  • Use humidity-sensing extractor fans. These switch on automatically when humidity rises and off when it falls.

    • Choose one with a humidistat and timer, vented directly outdoors (not into a loft or wall cavity).

    • Clean the fan cover and check filters every few months.

  • Dry laundry safely. Use a vented or condenser tumble dryer and empty or clean filters and tanks regularly.

    • Avoid drying clothes on radiators unless you’re using a dehumidifier or have good airflow.

  • Monitor humidity. Use a small digital hygrometer to track RH in different rooms.

    • Aim for 40–60% most of the time — this discourages mould and keeps air comfortable.

    • Above 60% for long periods encourages condensation and spores; below 35% can dry and irritate airways.

  • Use the right size dehumidifier.

    • Check the model’s rated room area (m²) or litres per day extraction rate.

    • A compact unit may cope with a small bedroom or bathroom but not a whole flat or open-plan area.

    • Keep doors closed while it’s running for best results, and empty and clean the water tank regularly to prevent bacterial build-up.

Control Dust and Irritants

  • Vacuum regularly with a HEPA-filtered vacuum cleaner.

  • Use microfibre cloths for dusting rather than dry dusters that stir particles into the air.

  • Avoid strongly fragranced cleaning products, candles, incense, and air fresheners — they release fine particles and chemicals that irritate sensitive lungs.

  • Choose low-VOC (low-odour) paints and furnishings when redecorating.

Keep Air Clean

  • If you live near traffic or building work, keep windows closed during busy times and ventilate later.

  • A room air purifier with a true HEPA filter can remove dust, pollen, and fungal spores effectively.

  • Choose the right size for your room.

    • Check the purifier’s Clean Air Delivery Rate (CADR) or maximum room coverage and ensure it matches or slightly exceeds your room size.

    • A small desktop purifier won’t clean a large living room or bedroom effectively.

    • For open-plan or high-ceiling spaces, you may need more than one unit.

  • Maintain it properly:

    • Replace or clean filters exactly as the manufacturer recommends (usually every 6–12 months).

    • Never wash or vacuum a disposable HEPA filter unless the manual allows it.

    • A clogged or undersized filter won’t clean air effectively and may re-release particles.

🌤️ Knowing When the Outside Air Is Clean — and How to Filter It Indoors

1. Check Air Quality Before Ventilating

It isn’t always obvious when outdoor air is safe to bring inside.
Modern air-quality data helps you choose the best times to open windows or run fans.

How to check:

  • Use free apps such as Air Quality Index (AQI) UK, Breezometer, Plume Labs, or AirVisual.

  • Visit DEFRA’s UK Air Information or check BBC Weather → Air Quality.

  • Look for PM2.5 (fine particles) and NO₂ (traffic pollution) levels — these are key irritants for sensitive lungs.

  • “Good” or “Low” readings mean it’s a good time to ventilate or air rooms.

  • Avoid opening windows near busy roads during rush hour or when pollution alerts are issued.

💡 Tip: Air quality is often better early in the morning or late in the evening when traffic and heat are lower.

2. Filter the Air as It Comes In

If you live near roads, building work, or farmland, you can reduce what enters while keeping ventilation safe:

🪟 Window Vent Filters

  • Many modern trickle vents can take fine mesh or electrostatic filters to trap pollen, dust, and spores.

  • Replace or wash filters regularly — clogged filters restrict airflow.

🌀 Filtered Ventilation Systems

  • MVHR systems (Mechanical Ventilation with Heat Recovery) pull in outdoor air, filter it, and expel stale indoor air — great for energy-efficient or damp-prone homes.

    • They help control humidity and filter pollutants.

    • Filters must be cleaned or replaced every few months.

  • Positive Input Ventilation (PIV) systems bring in filtered air gently from a roof or external vent, improving airflow and reducing condensation.

🧺 DIY Improvements

  • Clip-on intake filters can fit over some wall vents or fan inlets.

  • Use a portable HEPA purifier placed near an open window to “clean” incoming air as it circulates.

  • Keep window ledges, vent grilles, and trickle vents dust-free — they collect spores over time.

3. Balance Fresh Air and Safety

It’s important not to seal up a home completely — stale, humid air encourages mould.
The goal is controlled ventilation:

  • Ventilate when outdoor air is cleanest and driest.

  • Keep extractor fans running during steamy activities.

  • When outdoor air quality is poor, use purifiers and dehumidifiers indoors until it improves.

4. Low-Cost Monitoring at Home

You can buy small indoor/outdoor air-quality monitors that track PM2.5, temperature, and humidity.
These help you:

  • Spot pollution drifting indoors (from traffic, wood smoke, etc.).

  • Choose the best times to ventilate.

  • See how quickly humidity or particles fall after cooking or cleaning.

🌱 Summary

What to Do Why It Helps
Check local air-quality apps before opening windows Avoids letting polluted air inside
Ventilate during low-pollution hours Brings in cleaner, fresher air
Fit filters to vents or use MVHR/PIV systems Reduces dust and spores from incoming air
Clean vents, trickle filters, and window frames regularly Prevents build-up of trapped dust
Use a portable HEPA purifier near open windows Cleans incoming air in real time

🧽 Dealing with Mould and Dust Safely

Even in well-kept homes, mould and dust can build up in damp weather or hidden corners. If you see black or green patches, or notice a musty smell, act promptly — but take care to protect your lungs.

⚠️ Before You Start

  • Protect yourself: wear a well-fitted FFP2 or N95 mask, gloves, and, if possible, eye protection.

  • Avoid dry brushing or vacuuming visible mould — this can spread spores into the air.

  • Keep the area well ventilated but close doors to other rooms so spores don’t travel.

  • If the mould covers more than 1 square metre, keeps returning, or is linked to a leak, ask your landlord or council for professional help.

🧴 Cleaning Small Areas of Mould

  1. Wipe gently — don’t scrape.
    Use disposable cloths or ones you can boil-wash later. Avoid wire brushes.

  2. Use mild cleaning solutions:

    • Mix a few drops of washing-up liquid in warm water, or

    • Use a dilute bleach solution (1 part thin bleach to 9 parts water) on tiles or uPVC — ventilate well and never mix bleach with other cleaners, or

    • Try a specialist anti-fungal cleaner for painted or porous surfaces.

  3. Dry the area thoroughly.
    Use ventilation or a dehumidifier; mould will return if the surface stays damp.

  4. Dispose of cloths and gloves in a sealed bag. Wash hands well afterwards.

🧹 Managing Dust and Allergens

  • Vacuum at least twice weekly with a HEPA-filtered cleaner.

  • Dust with a damp microfibre cloth, not a feather duster.

  • Wash bedding and soft furnishings regularly at 60 °C if the fabric allows.

  • Avoid clutter that collects dust (papers, books, soft toys).

  • Keep humidity within 40–60% and fix damp quickly.

🌱 Preventing Mould and Dust Returning

Action Why It Helps
Find and fix leaks or condensation sources Mould needs moisture to grow
Ventilate kitchens, bathrooms, and drying areas Removes steam before it spreads
Use humidity-sensing fans or dehumidifiers Keeps humidity in a safe range
Maintain a steady indoor temperature Reduces cold surfaces and condensation
Close doors during steamy activities Stops damp air moving into other rooms
Replace or clean HEPA filters regularly Maintains air-cleaning performance
Check behind furniture and on windowsills Finds hidden damp early
Repaint cleaned areas with mould-resistant paint Discourages regrowth

🚫 What Not to Do

  • Don’t paint over mould — it will grow back.

  • Don’t use strong chemicals or foggers in small spaces — they can irritate lungs.

  • Don’t use steam cleaners on large mould patches — they can spread spores.

  • Don’t ignore damp smells — they always mean hidden moisture somewhere.

💼 At Work

  • Ask about ventilation and report any damp, leaks, or condensation.

  • Keep your workspace tidy and free of dust-collecting clutter.

  • If cleaning sprays or perfumes cause coughing, discuss adjustments with your manager or occupational health team.

✈️ When Travelling

  • Check air-quality forecasts before travelling and avoid outdoor activity on high-pollution or pollen days.

  • Choose clean, dry accommodation — avoid musty or damp-smelling rooms.

  • Pack a small hygrometer or travel dehumidifier for longer stays.

  • Use a well-fitted FFP2 or N95 mask in crowded or polluted environments.

  • Stay hydrated and pace activities in humid or hot weather.

🩺 Listen to Your Body

Keep a short diary of when and where your symptoms flare up, along with temperature, humidity, or smells you notice. Patterns often reveal your personal triggers.

🌱 Key Points

Good Practice Why It Matters
Keep home dry, clean, and ventilated Reduces mould and spore exposure
If it smells damp, it probably is Early warning of hidden moisture
Humidity above 60% after showering or cooking is normal — keep it short Prevents condensation and mould
Close doors while cooking, showering, or drying laundry Stops moisture spreading
Use humidity-sensing extractor fans Clears steam automatically
Monitor humidity (40–60%) Keeps air comfortable and discourages spores
Match HEPA filters and dehumidifiers to room size Ensures real air-cleaning and drying effect
Maintain and replace filters regularly Keeps air safe and fresh
Check outside air quality before opening windows Avoids bringing pollution indoors
Filter incoming air with vents or MVHR/PIV systems Keeps dust and spores out
Clean small mould patches safely with mild detergent Removes spores without irritation
Fix leaks, repaint with mould-resistant paint Prevents regrowth
Avoid strong scents and aerosols Reduces airway irritation
Plan travel around clean-air days Lowers risk of flares and infections

💬 Final Thought

You can’t control every environment — but small, steady habits make a big difference.
If something smells damp, it probably is. Deal with it early, clean gently, dry thoroughly, and keep air moving.
Short humidity spikes after showering or cooking are normal — just make sure they don’t linger.
Choose purifiers and dehumidifiers that are the right size for your rooms, and maintain them well.
Check outdoor air quality before airing your home, and use filters to keep what’s good while blocking what’s not.
A dry, clean, well-ventilated home gives your lungs the best chance to stay healthy every day — wherever you are.

by GAtherton

🩺 Why New Antifungal Medicines Aren’t for Everyone (Yet)

When new medicines are announced, it’s natural to wonder:

“If they’re better than what we already have, why can’t everyone start using them straight away?”

Two new antifungal drugs — Olorofim and Fosmanogepix — are generating real excitement because they work in completely new ways and could help people whose fungal infections no longer respond to existing treatments.

But before any new drug becomes widely available, it must go through a careful process to make sure it’s safe, effective, affordable, and used in the right patients. Here’s why most people with aspergillosis will still be treated with existing antifungal medicines for now.

🧪 1. They’re Still Being Tested

Olorofim and Fosmanogepix are still classed as investigational medicines.
That means they have shown promise in early studies — especially for severe or drug-resistant infections — but they are not yet approved for general medical use.

Regulators such as the MHRA (UK), EMA (Europe), and FDA (USA) require large, carefully controlled studies to confirm:

  • that the drugs are safe for different types of patients,

  • that they work as well as or better than existing treatments, and

  • that the benefits clearly outweigh any risks.

Until that evidence is complete, they can only be prescribed within clinical trials or under special compassionate-use programmes at specialist hospitals.

💨 2. Different Types of Aspergillosis Need Different Treatments

Aspergillosis isn’t one single disease. It includes:

  • Invasive aspergillosis, a dangerous infection in people with weak immune systems.

  • Chronic pulmonary aspergillosis (CPA), a long-term infection in people with lung damage.

  • Allergic bronchopulmonary aspergillosis (ABPA), an allergic reaction rather than a true infection.

The new antifungals are currently being tested only for invasive aspergillosis — the most severe form.
They haven’t yet been studied in chronic or allergic forms like CPA or ABPA, so we don’t yet know if they would work or be safe for those conditions.

💊 3. Current Medicines Still Work Well for Most Patients

Existing antifungal drugs such as itraconazole, voriconazole, posaconazole, and isavuconazole remain effective for most people with aspergillosis.

Doctors already know:

  • how to monitor their levels in the blood,

  • how to manage side-effects, and

  • how to combine them safely with other medicines.

New drugs can bring new possibilities — but they can also bring unknown side-effects or interactions. Doctors need strong, long-term evidence before changing large numbers of patients to new treatments.

💷 4. Cost and Access Take Time

Developing antifungal drugs takes years and costs millions of pounds.
When a new medicine is finally approved, it is often very expensive at first.

In the UK, every new treatment must go through NICE (the National Institute for Health and Care Excellence).
NICE checks:

  • how well it works,

  • how safe it is, and

  • whether the NHS can afford to provide it fairly to all who need it.

Only once NICE recommends a drug can NHS England fund it for routine use — and even then, it may be limited to certain hospitals or patient groups at first.

⚖️ 5. A Step-by-Step Approach Keeps Patients Safe

New medicines are introduced gradually — starting with people who have no other treatment options.
If they prove safe, effective, and affordable in that group, their use can be expanded step by step to include more patients and other forms of disease.

This careful rollout protects patients from unexpected risks and helps prevent early resistance, so the drugs stay effective for longer.

🧭 6. Who Decides When a New Antifungal Can Be Used for CPA?

Bringing a new antifungal from its first approval to wider use in chronic diseases like CPA involves several levels of decision-making:

1️⃣ The Manufacturer

Companies such as Shionogi Europe (Olorofim) or Basilea/Pfizer (Fosmanogepix) design the trials and decide which conditions to test first — usually the most life-threatening ones.
If early results are good, they can plan new studies for CPA or other chronic lung infections.

2️⃣ Clinical Researchers and Specialist Centres

Centres such as the National Aspergillosis Centre (NAC) collect real-world data from patients who receive these drugs through compassionate-use programmes.
If several patients with CPA improve, these results may encourage formal CPA-specific trials.

3️⃣ Regulatory Authorities

Bodies such as the MHRA (UK), EMA (Europe), or FDA (USA) decide which diseases a drug can officially be marketed for.
To add CPA as a licensed use, the company must submit:

  • new clinical trial data,

  • long-term safety information, and

  • a formal request to extend the drug’s licence.

Until that happens, doctors can only prescribe it for CPA off-label — usually within strict hospital governance systems.

4️⃣ NICE and NHS England

Even after regulatory approval, NICE must review cost and benefit before the NHS can fund the drug for CPA.
Without a positive NICE recommendation, it can’t be routinely prescribed in the UK.

5️⃣ Specialist Clinical Networks

Finally, once approved and funded, expert groups like the NAC and national respiratory networks decide how and when the drug should be used — for example:

  • only for patients with azole-resistant CPA,

  • after all standard options have failed, and

  • with careful monitoring.

This information is then built into national and local treatment guidelines.

🔄 Example Pathway: Olorofim’s Future Use for CPA

Stage Who acts What happens
1️⃣ Shionogi Gains approval for invasive aspergillosis
2️⃣ NAC & academic partners Report successful CPA case studies
3️⃣ Shionogi + NAC Launch a formal CPA clinical trial
4️⃣ MHRA / EMA Extend licence to include CPA
5️⃣ NICE Reviews cost-effectiveness for CPA
6️⃣ NHS England Approves CPA use in NHS centres

🩸 In Summary

Reason Why we can’t all switch now
Still in trials Not yet fully approved for use
Different diseases Only tested for invasive aspergillosis so far
Known vs unknown Established drugs work well for most people
Cost and access NHS approval and funding take time
Safe rollout New drugs introduced step-by-step

🌱 Looking Ahead

Both Olorofim and Fosmanogepix represent the most promising antifungal advances in decades.
If they continue to perform well in trials, they could become vital options for people whose infections no longer respond to standard medicines — and, in time, for chronic conditions like chronic pulmonary aspergillosis (CPA).

For now, the safest and most effective approach remains to use proven antifungals under expert supervision, while keeping a close watch on these exciting new developments.

by GAtherton

Understanding Risk: How Common Is “Rare”?

When doctors talk about risk, it can sound worrying — especially when you’re already living with a lung condition.
But every day, we all take small, managed risks without realising it.

Understanding how everyday risks compare with medical or vaccine risks helps put the numbers into perspective — and shows why treatment is almost always worth it.

🚶‍♀️ Everyday activities carry small risks

Everyday life is full of tiny risks we accept because the benefits are clear — exercise, travel, independence, and social connection.

Activity Estimated risk of serious harm Equivalent comparison
Driving a car for 250 miles About 1 in 1 million chance of fatal accident Roughly the same as the risk of a severe vaccine reaction
Cycling for 30 minutes About 1 in 3 million Similar to being struck by lightning in your lifetime
Walking near traffic for a day Around 1 in 15 million Negligible, but not zero
Taking a domestic flight (UK) Less than 1 in 10 million chance of fatal accident Far safer than most road journeys
Catching flu during winter Around 1 in 10 chance of getting ill Much higher risk than most medicine side effects

We don’t think of these activities as “dangerous” because the benefit far outweighs the risk — just as it does with most treatments.

💊 Medicines and vaccines we take safely every day

Most common medicines have mild, short-lived side effects. Serious reactions are possible but extremely rare.

Medicine Typical mild effects Serious reactions (approx. frequency) Comment
Paracetamol (acetaminophen) Nausea, rash Serious liver injury ≈ 1 in 100,000 (usually after overdose) Very safe when taken correctly
Ibuprofen Heartburn, upset stomach Ulcer or stomach bleed ≈ 1 in 1,000 if used long term Safer when taken with food
Amoxicillin Diarrhoea, mild rash Severe allergic reaction ≈ 1 in 5,000–10,000 Rare but recognised
Influenza vaccine Sore arm, tiredness Severe allergic reaction ≈ 1 in 1 million Prevents thousands of serious infections yearly
COVID-19 vaccine Mild flu-like symptoms (≈ 1 in 10) Severe allergic reaction ≈ 1 in 100,000 Benefits far outweigh risks
Oral steroids (short course) Increased appetite, insomnia Major side effects only with prolonged use Vital during ABPA or asthma flares

⚕️ What does “serious side effect” really mean?

When you read about serious reactions in medical leaflets or vaccine information, it doesn’t necessarily mean life-changing.
The term “serious” has a specific medical meaning, used by the MHRA, EMA, and WHO.

A reaction is called serious if it:

  • leads to hospitalisation,

  • is life-threatening at the time,

  • causes temporary disability or incapacity,

  • results in death, or

  • causes a birth defect.

👉 It’s about medical urgency, not always long-term harm.

In reality, most serious reactions are short-lived and fully reversible with prompt treatment.
For example:

  • An anaphylactic reaction to a vaccine is medically serious because it needs immediate care — but nearly everyone recovers completely once treated.

  • A high fever or rash that requires a day in hospital may be serious in reporting terms, but causes no permanent damage.

By contrast, life-changing reactions (such as nerve injury or organ failure) are extraordinarily rare — far rarer than being struck by lightning.

“When doctors say ‘serious reaction’, they mean something that needs urgent medical attention — not something that will leave you permanently unwell.”

🩺 More common health risks we all face

While medicine risks are very small, the everyday risks to life and health are much higher — especially if conditions go untreated.

Health event or cause Approximate annual risk (UK adult) Lifetime risk Notes
Heart attack Around 1 in 200–300 per year 1 in 4 men, 1 in 6 women Increases with age, smoking, and high blood pressure
Stroke Around 1 in 250 per year About 1 in 5 adults Preventable with healthy lifestyle and medication
Cancer (any type) Around 1 in 125 per year Around 1 in 2 people in their lifetime Most treatable when found early
Serious road accident About 1 in 15,000 per year Around 1 in 100 lifetime Far higher than a vaccine reaction
Severe flu needing hospital care Around 1 in 500 per winter Higher for people with lung disease Preventable by flu vaccination
Fatal asthma attack About 1 in 100,000 per year Higher in uncontrolled asthma Preventable with good management
COVID-19 death (current UK levels) Around 1 in 2,000–5,000 per year for older/vulnerable adults Major reason vaccination still matters
Lightning strike About 1 in 15 million per year Around 1 in 300,000 lifetime Benchmark for “extremely rare” risk

⚖️ Making sense of the numbers

  • A 1 in 1,000 risk means one person in a large GP practice might experience it.

  • A 1 in 100,000 risk means one person in a football stadium crowd.

  • A 1 in 1 million risk is so rare that most doctors never see it in their career.

So when you hear that a serious vaccine reaction occurs in one in a million people, that’s about the same as:

  • being struck by lightning once in your life, or

  • winning a small lottery prize several times in a row.

❤️ The real takeaway

The greatest risks to life and health are the common diseases we can prevent or treat — not the rare side effects of treatment.

Every vaccine or medicine is carefully assessed so that its benefits far outweigh its risks, especially for people with asthma, ABPA, bronchiectasis, or weakened immunity.
Treatments don’t add danger — they reduce the much bigger risks from infection, inflammation, and lung damage.

🧭 Key message

We all live with risk, but:

  • Most everyday and health-related risks are far greater than the tiny chance of a medicine reaction.

  • Managing your lung condition well — with the right treatment, vaccines, and follow-up — protects your lungs and lengthens your life.

  • The safest path is always informed care, not avoidance through fear.

by GAtherton